Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors. - Nojiri T; Omura A; Nishimura H; Iede K; Takeyasu Y; Katsushima U; Higashiyama M (Cancer diagnosis & prognosis, 2026)